Dr. Kraisorn Supports Medical Cannabis Use Amidst Calls for Legal Framework

By Thailand THC



thailandTHC > News > Dr. Kraisorn Supports Medical Cannabis Use Amidst Calls for Legal Framework

Last updated on June 25th, 2024 at 08:55 am

  • Driving The News: Dr. Kraisorn Woradithee, founder of Waradithee Medical Cannabis Clinic, calls for a comprehensive Cannabis Control Act to ensure safe medical use and protect patients.
  • Why It Matters: Proper legislation is essential for balancing the medical benefits of cannabis with the need to prevent misuse and ensure patient safety.
  • The Big Picture: The push for a Cannabis Control Act reflects the broader need for science-based regulation that supports medical practitioners and patients.

BANGKOK, THAILAND – On June 5, Dr. KRAISORN WORADITHEE, founder of the Waradithee Medical Cannabis Clinic, addressed the growing controversy surrounding efforts to reclassify cannabis as a narcotic. Dr. Kraisorn emphasized the need for a comprehensive Cannabis Control Act to regulate cannabis use, particularly for medical purposes.

Dr. Kraisorn supports the diverse medical applications of cannabis, which include treating various diseases and symptoms in conjunction with traditional and modern medicine. He noted that cannabis can effectively replace central nervous system medications like sleeping pills, anti-anxiety drugs, and antidepressants. He also pointed out that many working individuals and villagers seek cannabis extracts to relieve stress and promote relaxation.

“I do not support recreational use, but I do advocate for the medical use of cannabis to help patients quit methamphetamine and heroin,” Dr. Kraisorn stated. “Using cannabis for medical treatment has shown good results. Reclassifying cannabis as a narcotic would create significant limitations for Thai traditional medicine practitioners, village doctors, and those trained to use cannabis correctly.”

Dr. Kraisorn stressed the importance of enacting legislation to regulate cannabis use rather than imposing restrictive measures that could hinder its medical benefits. “We need laws to manage cannabis use effectively, rather than creating obstacles that discourage its use,” he said. “Ultimately, we must consider the broad impact on patients, traditional medicine practitioners, and entrepreneurs who rely on cannabis for treatment.”

He urged the government to complete the legislative process for a Cannabis Control Act, which has been in progress for some time. “We have come a long way with cannabis. Let’s continue to develop its use appropriately,” Dr. Kraisorn concluded.

Contributing Sources: Manager Online

.